INSULIN GLARGINE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2022-02-07
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:20:09
Label at a glance#
ProductINSULIN GLARGINE
Active ingredientINSULIN GLARGINE
Products#
Every source-derived product name is available through these pages.
- INSULIN GLARGINE
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| INSULIN GLARGINE | 2ZM8CX04RZ | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BASAGLAR KwikPen | INSULIN GLARGINE | Eli Lilly and Company | 0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae | 2026-06-16 | Warnings, Adverse reactions | INSULIN GLARGINE |
| Insulin Glargine | INSULIN GLARGINE-YFGN | Biocon Biologics Inc. | 3ac85ebb-5594-59c8-77fd-df254329d151 | 2026-01-23 | Warnings, Adverse reactions | Insulin Glargine |
| INSULIN GLARGINE | INSULIN GLARGINE-YFGN | Civica, Inc. | 72cfe377-52f6-0348-fc71-5d4ac1992ffb | 2025-07-24 | Warnings, Adverse reactions | INSULIN GLARGINE |
| INSULIN GLARGINE | INSULIN GLARGINE-YFGN | Civica, Inc. | 216f2167-c201-76fe-81ed-0d51fe53832f | 2025-07-03 | Warnings, Adverse reactions | INSULIN GLARGINE |
| Lantus Solostar | INSULIN GLARGINE | sanofi-aventis U.S. LLC | d5e07a0c-7e14-4756-9152-9fea485d654a | 2025-06-02 | Warnings, Adverse reactions | INSULIN GLARGINE |
| TOUJEO | INSULIN GLARGINE | Sanofi-Aventis U.S. LLC | c9561d96-124d-48ca-982f-0aa1575bff36 | 2025-05-30 | Warnings, Adverse reactions | INSULIN GLARGINE |
| Insulin glargine U-300 Max | INSULIN GLARGINE | Sanofi-Aventis U.S. LLC | 99ea856d-9562-443a-9422-1006a3cff2f4 | 2025-05-30 | Warnings, Adverse reactions | INSULIN GLARGINE |
| LANTUS SOLOSTAR | INSULIN GLARGINE | A-S Medication Solutions | 3a97c40f-0c83-42d7-a8ee-484b208db4e3 | 2023-07-22 | Warnings, Adverse reactions | INSULIN GLARGINE |
| TOUJEO Max | INSULIN GLARGINE | A-S Medication Solutions | 620b9a3d-8d8c-4c0a-b5a2-f269d6cc9ab9 | 2023-07-12 | Warnings, Adverse reactions | INSULIN GLARGINE |
| Lantus Solostar | INSULIN GLARGINE | A-S Medication Solutions | 632d9f68-f184-43d5-b184-a3af23f12ad9 | 2023-06-06 | Warnings, Adverse reactions | INSULIN GLARGINE |
| TOUJEO | INSULIN GLARGINE | A-S Medication Solutions | 257ca17b-6ff7-4f2e-9037-4c185bac5768 | 2023-04-27 | Warnings, Adverse reactions | INSULIN GLARGINE |
| Lantus | INSULIN GLARGINE | A-S Medication Solutions | ae27bb66-5dbe-4f01-a89e-f4fa7cb09c99 | 2023-02-04 | Warnings, Adverse reactions | INSULIN GLARGINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.